Compare MNY & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MNY | ONMD |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | Singapore | United States |
| Employees | 240 | 23 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 35.9M |
| IPO Year | N/A | N/A |
| Metric | MNY | ONMD |
|---|---|---|
| Price | $0.97 | $0.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 24.0K | ★ 131.5K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.58 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.78 | $0.44 |
| 52 Week High | $2.40 | $4.22 |
| Indicator | MNY | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.76 | 42.14 |
| Support Level | $0.78 | $0.59 |
| Resistance Level | $1.03 | $0.96 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 30.84 | 28.50 |
MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.